# OnCo record gestational-trophoblastic (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/gestational-trophoblastic/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "gestational-trophoblastic" ;
  schema:name "Gestational trophoblastic neoplasia"@en ;
  schema:alternateName "GTN"@en, "Choriocarcinoma"@en, "Molar pregnancy"@en, "Placental site trophoblastic tumour"@en, "Gestational Trophoblastic Disease"@en ;
  schema:description "Cancers that grow from placental tissue after a pregnancy. They make a hormone (hCG) that acts as a perfect blood test, and they were the first solid cancer ever cured by chemotherapy. Immunotherapy now rescues the few that resist drugs."@en ;
  schema:url <https://onco.cc/cancers/gestational-trophoblastic/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Gestational_trophoblastic_disease> ;
  owl:sameAs <http://www.wikidata.org/entity/Q3433884> ;
  schema:citation <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1489>, <https://www.cancer.gov/types/gestational-trophoblastic/patient/gtd-treatment-pdq> ;
  onco:tag "gap-fill", "gynaecologic", "rare" ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/ultrasound/>, <https://onco.cc/technologies/fertility-preservation/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/dactinomycin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/avelumab/> ;
  onco:companies <https://onco.cc/companies/merck/>, <https://onco.cc/companies/pfizer/> ;
  onco:pathways <https://onco.cc/pathways/pd1-checkpoint/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/avelumab/> ;
  onco:standardOfCare <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/dactinomycin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/dactinomycin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/avelumab/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/etoposide/> .